Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

Hinge Bio
$13,000,000
Series A Convertible Preferred StockSole Placement Agent
February 2020
Imunon
$4,800,000
Registered DirectFinancial Advisor
February 2020
Vaxart
$10,000,000
Registered DirectCo-Placement Agent
February 2020
DoubleLine Yield Opportunities Fund
$920,000,000
IPOCo-Manager
February 2020
Edesa Biotech
$4,400,000
Registered DirectSole Placement Agent
January 2020
NightHawk Biosciences
$7,000,000
Follow-OnCo-Manager
January 2020
BlackRock Capital Allocation Trust
$2,100,000,000
IPOCo-Manager
January 2020
Scynexis
$40,250,000
Follow-OnCo-Manager
December 2019
Peerbridge Health
$11,000,000
Convertible NotePlacement Agent
December 2019
Imunon
Completed EngagementCapital Markets Advisor
December 2019
Aquestive Therapeutics
$40,300,000
Follow-OnCo-Manager
December 2019
Neumentum
$7,100,000
Convertible NoteSub Placement Agent
December 2019
Monopar Therapeutics
$10,200,000
IPOCo-Manager
December 2019
Calamos Long/Short Equity & Dynamic Income Trust
$365,000,000
IPOCo-Manager
November 2019
Diffusion Pharmaceuticals
Completed EngagementCapital Markets Advisor
November 2019
Aquestive Therapeutics
Completed EngagementCapital Markets Advisor
November 2019
Verastem Oncology
$114,300,000
Public Convertible Debt ExchangeImmediately Redeemable
November 2019
Union Acquisition Corp.
$200,000,000
IPOCo-Manager
October 2019
Allianz AI Opportunities Fund
$615,000,000
IPOCo-Manager
October 2019
Vaxart
$8,700,000
Follow-OnCo-Manager
September 2019
Betaliq
$7,500,000
Series A Convertible Preferred StockExclusive Placement Agent
September 2019
Jerrick Media
Acquisition
"Seller's Choice"Buy-Side Advisor
September 2019
Nuveen Dynamic Municipal Opportunities Fund
$810,000,000
IPOCo-Manager
September 2019
BioCardia
$10,500,000
Follow-OnCo-Manager
August 2019